Ask AI
ProCE Banner Activity

The APP’s Guide to Patient-Centered Management of CDK4/6 Inhibitor Therapy for HR+/HER2- Breast Cancer

Slideset

Download this slideset covering the latest information on CDK4/6 inhibitor therapy for HR-positive/HER2-negative breast cancer that advanced practitioners need to know including the latest recommendations for managing treatment-related adverse events, strategies to promote patient adherence to treatment plans, and available resources for you and your patients.

Released: September 19, 2025

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Clinical Care Options, LLC

ProCE Banner